Imax price target raised to $22 from $20 at Barrington

Barrington analyst James Goss raised the firm’s price target on Imax to $22 from $20 and keeps an Outperform rating on the shares after the company reported Q4 results that were boosted by "Avatar: The Way of Water," which released at the end of 2022 and saw its momentum carry over into early 2023. Barrington, which expects the U.S., China and the rest of the world to "all fairly equally" contribute to roughly $1.1B in Imax global box office in 2023, includes the stock on the firm’s "Best Ideas List."